interferon alpha (DURECT/BioPartners)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon alpha (DURECT/BioPartners)
Drug Alias NameSABER (DURECT/BioPartners)sustained-release IFN alpha (DURECT/BioPartners)SABER (DURECT/BioPartners)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiopartners Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDurect CorpBiopartners Gmbh
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A